Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy

Joseph Hadaya1, Arjun Verma1, Yas Sanaiha1

  • 1Division of Cardiac Surgery, Department of Surgery, David Geffen School of Medicine at University of California-Las Angeles, CA.

Surgery
|May 25, 2023
PubMed

Insights

Higher septal myectomy volume at hospitals is linked to better outcomes for hypertrophic obstructive cardiomyopathy patients. This includes lower mortality and readmission rates, and more mitral valve repairs.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Health Services Research

Background:

  • Septal myectomy is the primary treatment for severe hypertrophic obstructive cardiomyopathy.
  • Patient outcomes can be influenced by hospital procedure volume.

Purpose of the Study:

  • To investigate the association between hospital septal myectomy volume and cardiac surgery volume with patient outcomes.
  • To determine if higher procedural volume correlates with improved results in septal myectomy patients.

Main Methods:

  • Analysis of adult patients undergoing septal myectomy from the 2016-2019 Nationwide Readmissions Database.
  • Hospitals categorized into low-, medium-, and high-volume based on septal myectomy caseload.
  • Generalized linear models used to assess outcomes including mortality, mitral valve intervention, and readmission.

Main Results:

  • High-volume hospitals showed reduced odds of mortality (0.24) and 90-day readmission (0.59) compared to low-volume hospitals.
  • Patients at high-volume centers were more likely to undergo mitral valve repair versus replacement (OR 5.33).
  • Overall cardiac surgery volume did not correlate with any studied outcomes.

Conclusions:

  • Increased septal myectomy volume is associated with improved patient outcomes, including lower mortality and higher rates of mitral valve repair.
  • These findings support performing septal myectomy at specialized centers with high procedural expertise.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
19
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12